(firstQuint)Efficacy of Aprepitant (Emend) in Children.

 1.

1 Primary Aim To determine the efficacy of aprepitant (Emend(R)) in preventing and reducing chemotherapy-induced nausea and vomiting (CINV) when added to standard antiemetic drug regimens for children receiving highly emetogenic chemotherapy.

 The working hypothesis will be that standard therapy + aprepitant is superior at preventing CINV than standard therapy + placebo.

 1.

2 Secondary Aim To evaluate the safety and toxicity of aprepitant (Emend(R)) in children receiving highly emetogenic chemotherapy when compared to standard antiemetic therapy + placebo.

.

 Efficacy of Aprepitant (Emend) in Children@highlight

The purpose of this study is to find out whether or not adding aprepitant(Emend(R)) to the standard therapy will help children who receive chemotherapy to have less nausea and vomiting.

